We read with great interest an article recently published in Clinical Liver Disease by Herbst and Reddy,1 who reviewed the risk factors for hepatocellular carcinoma. They mentioned that current guidelines do not recommend regular surveillance for hepatocellular carcinoma in hepatitis C patients without cirrhosis. However, one issue should be clarified. If clinicians are not performing regular surveillance for patients with hepatitis C, how can they know if these patients already have cirrhosis in clinical practice? In other words, if cirrhosis is not diagnosed, these patients will never have the chance to use these guidelines. Could the authors comment?
Watch a video presentation of this article
To the Editor:
Shih-Wei Lai M.D.* , Kuan-Fu Liao M.S., M.D. § ¶, , * School of Medicine, Graduate Institute of Integrated Medicine China Medical University Taichung, Taiwan, Department of Family Medicine China Medical University Hospital Taichung, Taiwan, § Department of Internal Medicine Taichung Tzu Chi General Hospital Taichung, Taiwan, ¶ Department of Health Care Administration Central Taiwan University of Science and Technology Taichung, Taiwan.